Indoco Remedies Limited — Updates, 30-10-2024: Press Release
30-10-2024 · 11:36 am
Indoco Remedies Limited has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Varenicline Tablets in 0.5 mg and 1 mg dosages, a generic version of Chantix. Manufactured at their Goa facility, these tablets are used to assist in smoking cessation. Managing Director Aditi Panandikar emphasized this achievement as a testament to Indoco's quality standards and growth potential in the US market.
No comments yet. Be the first to comment!
